Dry Age-related Macular Degeneration Clinical Trials

54 clinical trials for Dry Age-related Macular Degeneration across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration — RECRUITING · PHASE1
• (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000 — RECRUITING · NA
• A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) — RECRUITING · PHASE2
• A multicenter, prospective, randomized, masked control trial to assess the safety and clinical benefit of the MACULIGHT medical device for PBM home therapy in subjects with dry age-related macular degeneration — RECRUITING
• Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) — RECRUITING · PHASE1
• Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma — RECRUITING · NA
• Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma. — RECRUITING · NA
• A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT) — RECRUITING
• Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study — RECRUITING · PHASE3
• A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration — COMPLETED · PHASE1
• Evaluation of an Electric Stimulator for Medical Use by Personal (LRTPM1) for Visual Function in Early to Intermediate Dry Age-Related Macular Degeneration — NOT_YET_RECRUITING · NA
• PRIMA US-Feasibility Study in Atrophic Dry AMD — ACTIVE_NOT_RECRUITING · NA
• Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration — COMPLETED · NA
• An open-label safety and tolerability clinical trial of PST-611 in dry age-related macular degeneration. — TERMINATED · PHASE1
• Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration — COMPLETED · NA
• ReNEW: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects who have Dry Age-Related Macular Degeneration (Dry AMD) — TERMINATED · PHASE3
• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD — TERMINATED · PHASE1
• HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 — TERMINATED · PHASE2
• EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 — TERMINATED · PHASE2
• Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) — COMPLETED · NA
• Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study — ACTIVE_NOT_RECRUITING
• Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration — COMPLETED · PHASE2
• Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59 — COMPLETED · PHASE1
• Study to Detect Dendritic Cell Recruitment in Human Retina — NOT_YET_RECRUITING
• A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration — COMPLETED · PHASE1
• Hyperspectral Drusen Classification — COMPLETED
• QA102 Phase II Study in Subjects With Dry AMD — COMPLETED · PHASE2
• Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration — COMPLETED · PHASE1
• GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) — TERMINATED
• Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) — OTHER · PHASE2
• A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD — TERMINATED · PHASE1
• Vision Improvement for Legally Blind Dry AMD Patients — NOT_YET_RECRUITING
• Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85 — COMPLETED · PHASE1
• CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration — COMPLETED · PHASE3
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration — TERMINATED · PHASE2
• Observation of the Natural Course of Age-related Macular Degeneration — NOT_YET_RECRUITING
• Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II) — COMPLETED · NA
• Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA) — WITHDRAWN · PHASE2
• Microcurrent Stimulation for Dry Age-related Macular Degeneration — WITHDRAWN · NA
• Observational Study of Vision Improvement in Late Stage Dry AMD Patients — COMPLETED
• First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration — COMPLETED · PHASE1
• Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) — ACTIVE_NOT_RECRUITING · NA
• A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration — COMPLETED · PHASE2
• A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration — COMPLETED · PHASE2
• Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases — OTHER · PHASE1
• Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells — OTHER · PHASE1
• The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD — OTHER · PHASE1
• Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration. — COMPLETED · PHASE2
• Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy — COMPLETED · PHASE2
• Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration — SUSPENDED · PHASE1

Refine this search